France · Source-listed medicine information

France / CIS 66694372

IOPAMIRON 300 (300 mg d'Iode par mL), solution injectable

solution injectable · intraarticulaire / intraartérielle / intrathécale / intraveineuse

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formsolution injectable
Routeintraarticulaire / intraartérielle / intrathécale / intraveineuse
Ingredient entries2
CountryFrance

Product identity

At a glance

Authorisation holder
BRACCO IMAGING FRANCE
Authorisation status
Autorisation active
Market status
Commercialisée
Country
France
Source reference
CIS 66694372

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for IOPAMIRON 300 (300 mg d'Iode par mL), solution injectable
IngredientStrength / referenceSource role
IODEsolution30 g100 ml de solutionFTGroup 1
IOPAMIDOLsolution61,240 g100 ml de solutionSAGroup 1

Pack references

Presentations (5)

1 flacon(s) en verre de 10 ml

CIP13 3400932458837

Présentation active · Déclaration de commercialisation
1 flacon(s) en verre de 50 ml

CIP13 3400932459087

Présentation active · Déclaration d'arrêt de commercialisation
1 flacon(s) en verre de 100 ml

CIP13 3400932459148

Présentation active · Déclaration d'arrêt de commercialisation
1 flacon(s) en verre de 200 ml

CIP13 3400932459209

Présentation active · Déclaration d'arrêt de commercialisation
10 flacon(s) en verre de 200 ml

CIP13 3400955920052

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 66694372 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source fileRetrievedSource file modified
fr_products.txtNot supplied
fr_composition.txtNot supplied
fr_packs.txtNot supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →